BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu TH, Wang YC, Cheng CH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(1): 17-27 [PMID: 31984121 DOI: 10.4240/wjgs.v12.i1.17]
URL: https://www.wjgnet.com/1948-9366/full/v12/i1/17.htm
Number Citing Articles
1
Kohei Ogawa, Yasutsugu Takada. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver TransplantationCancers 2022; 14(2): 396 doi: 10.3390/cancers14020396
2
Yi-Fan Tsou, Niang-Cheng Lin, Cheng-Yuan Hsia, Che-Chuan Loong, Hsin-Lin Tsai, Cheng-Yen Chen, Hao-Jan Lei, Shu-Cheng Chou, Meng-Hsuan Chung, Fang-Cheng Kuo, Chin-Su Liu. Repeated loco-regional therapies for hepatocellular carcinoma is associated with inferior outcome after living donor liver transplantation in cirrhotic patientsJournal of the Chinese Medical Association 2022; 85(3): 317 doi: 10.1097/JCMA.0000000000000670
3
Toshiaki Nakano, Chao-Long Chen, I-Hsuan Chen, Hui-Peng Tseng, Kuei-Chen Chiang, Chia-Yun Lai, Li-Wen Hsu, Shigeru Goto, Chih-Che Lin, Yu-Fan Cheng. Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive BiomarkerInternational Journal of Molecular Sciences 2023; 24(9): 7908 doi: 10.3390/ijms24097908